Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab

NCT00194714 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

HER2/Neu Positive
HLA-A2 Positive Cells Present
Stage IV Breast Cancer
Stage IV Ovarian Cancer

Interventions

BIOLOGICAL: HER-2/neu Peptide Vaccine
OTHER: Laboratory Biomarker Analysis

Sponsor

University of Washington

Collaborators

[object Object]